technology

Jan 05, 2021

Healthcare_researchBiotechnology – in the spotlight thanks to Covid-19 – surpasses even digital in terms of its scope to transform this century. Much of its funding comes from private equity, where investors face ethical as well as financial dilemmas. Alex Rolandi reports.

Jan 05, 2021

artificial intelligenceWhen it comes to companies and talent, an overriding issue for France is to keep hold of its homegrown fintechs and deter them from drifting overseas. Nicholas Pratt looks at how this is done.

Jan 04, 2021

Australian asset management, Australian superannuation schemesTesting financial conditions during 2020 have added to the pressure on Australia’s superannuation industry to deliver better investment outcomes and greater cost efficiency, according to Funds Global Asia’s 2020 Australia survey conducted in partnership with Calastone.

Dec 22, 2020

AI_investingThe artificial intelligence tipping point for portfolio management is not here yet, but the technology’s role in emulating human investment decision-making processes is becoming more prevalent in the fund industry.

Dec 21, 2020

MiFID II, data management, EMTA digital utility has managed to lower data management costs related to MiFID II by over £100,000 (€110,000) for firms involved in the project.

Dec 17, 2020

The Australian superannuation sector has been subject to scrutiny from financial supervisors and policymakers over the past four to five years in search of changes that will improve efficiency, extend product choice and enhance the investment outcomes that these deliver to scheme members.

Dec 17, 2020

From the impact of technology to the future of investment advice, how do the Australian survey’s findings compare with the rest of the world’s?

Dec 17, 2020

The next section evaluates which companies will be the most valuable partners to asset management firms in managing business innovation and which will be the primary point of disruption to the investment funds industry.

Dec 10, 2020

biotechnology_investmentWith the Covid-19 pandemic, biotechnology and Big Pharma are back in the spotlight. Investors in life sciences are essentially backing developments that could determine the future of the human race, but what does investing in ‘cures’ mean from a cashflow point of view?

Dec 08, 2020

Toby_GlaysherApplication Programming Interfaces (APIs) have helped revolutionise industries ranging from travel to hospitality. Toby Glaysher, Head of Global Fund Services, International at Northern Trust, outlines how they will play a similarly pivotal role in the digitalisation of asset management – encouraging collaboration to support enhanced efficiency, flexibility and creativity.

Pages